The Boston Globe -- THE SEPT. 27 editorial “No haven for dangerous drugs” overstates the impact of the Supreme Court’s 8-1 preemption decision in the medical device arena. The court’s decision does not grant immunity for medical device makers, but instead reaffirms well-established federal law.
